Related Experiment Video
Updated: Jul 19, 2026

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Clinical chemistry reference values for 75-year-old apparently healthy persons.
Klaus Roland Huber1, Nazanin Mostafaie, Gerhard Stangl
1Institute of Laboratory Medicine, Donauspital, Vienna, Austria. klaus.huber@wienkav.at
This study establishes reference values for 45 clinical chemistry analytes in 75-year-old individuals, differentiating normal aging from disease. These findings aid in understanding metabolic changes associated with aging.
Area of Science:
- Gerontology and Geriatric Medicine
- Clinical Biochemistry
- Metabolic Research
Background:
- Limited reference values exist for elderly populations, hindering differentiation between normal aging and disease-related metabolic changes.
- The Vienna Transdanube Aging (VITA) study aims to establish distinct physiological profiles for healthy elderly individuals.
- Over 600 volunteers aged exactly 75 years were recruited to isolate the effects of aging.
Purpose of the Study:
- To establish reliable clinical chemistry, hormonal, and hematological reference intervals for apparently healthy 75-year-old individuals.
- To differentiate normal physiological aging processes from metabolic alterations associated with disease in the elderly.
- To provide a baseline for future research correlating metabolic factors with aging and disease states.
Main Methods:
- Comprehensive clinical, neurological, biochemical, psychological, genetic, and radiological assessments were conducted.
- Participants were selected based on strict inclusion/exclusion criteria for a reference sample group.
- Automated and manual methods were used for analyte quantification, with statistical analysis performed using SPSS.
Main Results:
- Reference intervals for 45 analytes, including organ function parameters, hormone concentrations, and hematological appraisals, were established.
- A follow-up evaluation at age 77.5 years validated the initial findings and confirmed the cohort's health status.
- The second round of data corroborated the baseline reference limits and inclusion/exclusion criteria.
Conclusions:
- A reliable set of reference data for clinical chemistry, hormonal, and hematological analytes in elderly subjects has been successfully established.
- These reference values are crucial for future research endeavors.
- The data will facilitate correlation of disease states and aging processes with metabolic factors in the elderly.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age